The DOI matches its Crossref record; 135 of the 137 references it cites were found in a registry or an index.
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
Open accessAbstract
Hepatic cirrhosis and hepatocellular carcinoma (HCC) are the most common causes of death in patients with chronic liver disease. Chronic liver injury of virtually any etiology triggers inflammatory and wound-healing responses that in the long run promote the development of hepatic fibrosis and HCC. Here, we review the role of the transcription factor nuclear factor-κB (NF-κB), a master regulator of inflammation and cell death, in the development of hepatocellular injury, liver fibrosis and HCC, with a particular focus on the role of NF-κB in different cellular compartments of the liver. We propose that NF-κB acts as a central link between hepatic injury, fibrosis and HCC, and that it may represent a target for the prevention or treatment of liver fibrosis and HCC. However, NF-κB acts as a two-edged sword and inhibition of NF-κB may not only exert beneficial effects but also negatively impact hepatocyte viability, especially when NF-κB inhibition is pronounced. Finding appropriate targets or identifying drugs that either exert only a moderate effect on NF-κB activity or that can be specifically delivered to nonparenchymal cells will be essential to avoid the increase in liver injury associated with complete NF-κB blockade in hepatocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the decisive factor is that NF-κB-activation additionally causes a significantly increased resistance against apoptosis in aHSCs.[21]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Activators and Target Genes of Rel/NF-кB Transcription Factors
Loop, T., & Pahl, H. L. (2003) · Springer eBooks · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,179
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
Cited by
Sorted by citations
Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
Jia, W., Xie, G., & Jia, W. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.119 · Cited by 1,924
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dapito, D. H., Mencin, A., Gwak, G.-Y., Pradere, J.-P., Jang, M.-K., Mederacke, I., Caviglia, J. M., Khiabanian, H., Adeyemi, A., Bataller, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.007 · Cited by 1,346
Self-citationLiver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237
Macrophage heterogeneity in liver injury and fibrosis
Tacke, F., & Zimmermann, H. W. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.025 · Cited by 1,061
Hepatic inflammation and fibrosis: Functional links and key pathways
Seki, E., & Schwabe, R. F. (2015) · Hepatology · doi:10.1002/hep.27332 · Cited by 972
Self-citationEndoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease
Lebeaupin, C., Vallée, D., Hazari, Y., Hetz, C. A., Chevet, É., & Bailly‐Maitre, B. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.06.008 · Cited by 971
Grande, M. T., Sánchez‐Laorden, B. L., López-Blau, C., de Frutos, C. A., Boutet, A., Arévalo, M. A., Rowe, R. G., Weiss, S. J., López-Novoa, J. M., & Nieto, M. A. (2015) · Nature Medicine · doi:10.1038/nm.3901 · Cited by 787
Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance
Luedde, T., Kaplowitz, N., & Schwabe, R. F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.018 · Cited by 785
Self-citationRole of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
Hernández–Gea, V., Toffanin, S., Friedman, S. L., & Llovet, J. M. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.002 · Cited by 726
Pradere, J.-P., Kluwe, J., De Minicis, S., Jiao, J.-J., Gwak, G.-Y., Dapito, D. H., Jang, M.-K., Guenther, N. D., Mederacke, I., Friedman, R., et al. (2013) · Hepatology · doi:10.1002/hep.26429 · Cited by 613
Self-citationBaeck, C., Wehr, A., Karlmark, K. R., Heymann, F., Vucur, M., Gassler, N., Huss, S., Klussmann, S., Eulberg, D., Luedde, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300304 · Cited by 609
Self-citationInflammation-induced IgA+ cells dismantle anti-liver cancer immunity
Shalapour, S., Lin, X.-J., Bastian, I. N., Brain, J., Burt, A. D., Aksenov, A. A., Vrbanac, A. F., Li, W., Perkins, A., Matsutani, T., et al. (2017) · Nature · doi:10.1038/nature24302 · Cited by 589
Crosstalk between fibroblasts and inflammatory cells
Linthout, S. V., Miteva, K., & Tschöpe, C. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu062 · Cited by 588
Lampi, M. C., & Reinhart-King, C. A. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aao0475 · Cited by 551
The roles of signaling pathways in bone repair and regeneration
Majidinia, M., Sadeghpour, A., & Yousefi, B. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26042 · Cited by 526
Fibrosis-dependent mechanisms of hepatocarcinogenesis
Zhang, D. Y., & Friedman, S. L. (2012) · Hepatology · doi:10.1002/hep.25670 · Cited by 444
Capece, D., Fischietti, M., Verzella, D., Gaggiano, A., Cicciarelli, G., Tessitore, A., Zazzeroni, F., & Alesse, E. (2012) · BioMed Research International · doi:10.1155/2013/187204 · Cited by 414
Wells, R. G. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.02.007 · Cited by 384
Fang, Y., Chen, H., Wang, C., & Liang, L. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i27.2974 · Cited by 407
CCL5/CCR5 axis in human diseases and related treatments
Zeng, Z., Lan, T., Wei, Y., & Wei, X. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.08.004 · Cited by 396
Liu, Z., Wang, M., Wang, X., Bu, Q., Wang, Q., Su, W., Li, L., Zhou, H., & Lü, L. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102305 · Cited by 363
Zhao, Z., Xin, F., Xue, Y., Hu, Z., Han, Y., Ma, F., Zhou, D., Liu, X., Cui, A., Liu, Z., et al. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0304-5 · Cited by 357
Liedtke, C., Luedde, T., Sauerbruch, T., Scholten, D., Streetz, K. L., Tacke, F., Tolba, R. H., Trautwein, C., Trebicka, J., & Weiskirchen, R. (2013) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-6-19 · Cited by 346
Self-citationLau, E. Y.-T., Lo, J. H. T., Cheng, B. Y.-L., Ma, M. K. F., Lee, J. M. F., Ng, J. K. Y., Chai, S., Lin, C. H., Tsang, S. Y., Ma, S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.019 · Cited by 334
Kern, L., Mittenbühler, M., Vesting, A., Ostermann, A., Wunderlich, C., & Wunderlich, F. (2018) · Cancers · doi:10.3390/cancers11010024 · Cited by 331
Greene, C. M., Marciniak, S. J., Teckman, J. H., Ferrarotti, I., Brantly, M., Lomas, D. A., Stoller, J. K., & McElvaney, N. G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.51 · Cited by 332
Marquardt, J. U., Gómez-Quiroz, L. E., Camacho, L. O. A., Pinna, F., Lee, Y., Kitade, M., Domínguez, M. P., Castven, D., Breuhahn, K., Conner, E. A., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.018 · Cited by 313
Functional and genetic deconstruction of the cellular origin in liver cancer
Marquardt, J. U., Andersen, J. B., & Thorgeirsson, S. S. (2015) · Nature reviews. Cancer · doi:10.1038/nrc4017 · Cited by 306
Role of nonresolving inflammation in hepatocellular carcinoma development and progression
Yu, L., Yan, L., & Wang, H. (2018) · npj Precision Oncology · doi:10.1038/s41698-018-0048-z · Cited by 309
Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
Sun, E. J., Wankell, M., Palamuthusingam, P., McFarlane, C., & Hebbard, L. (2021) · Biomedicines · doi:10.3390/biomedicines9111639 · Cited by 292
Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight
Lohitesh, K., Chowdhury, R., & Mukherjee, S. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0538-7 · Cited by 274
Chen, S., Tan, Y., Xiao, X., Li, Q., Wu, Q., Peng, Y.-Y., Ren, J. T., & Dong, M. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00597-x · Cited by 266
Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies
Alqahtani, A., Khan, Z., Alloghbi, A., S. Said Ahmed, T., Ashraf, M., & M. Hammouda, D. (2019) · Medicina · doi:10.3390/medicina55090526 · Cited by 265
Nafees, S., Rashid, S., Ali, N., Hasan, S. K., & Sultana, S. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.02.021 · Cited by 267
Tumor Promotion via Injury- and Death-Induced Inflammation
Kuraishy, A. I., Karin, M., & Grivennikov, S. I. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.006 · Cited by 270
The Inflammation and Liver Cancer
Bishayee, A. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-0348-0837-8_16 · Cited by 263
Ramakrishna, G., Rastogi, A., Trehanpati, N., Sen, B., Khosla, R., & Sarin, S. K. (2013) · Liver Cancer · doi:10.1159/000343852 · Cited by 244
Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma
Hoshida, Y., Fuchs, B. C., Bardeesy, N. M., Baumert, T. F., & Chung, R. T. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.010 · Cited by 245
Prognostic Gene Expression Signature for Patients With Hepatitis C–Related Early-Stage Cirrhosis
Hoshida, Y., Villanueva, A., Sangiovanni, A., Solé, M., Hur, C., Andersson, K. L., Chung, R. T., Gould, J., Kojima, K., Gupta, S. K., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.021 · Cited by 228
Schneider, K. M., Mohs, A., Gui, W., Galvez, E. J. C., Candels, L. S., Hoenicke, L., Muthukumarasamy, U., Holland, C. H., Elfers, C., Kilic, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31312-5 · Cited by 225
Cellular and molecular mechanisms of hepatocellular carcinoma: an update
Aravalli, R. N., Cressman, E. N. K., & Steer, C. J. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0931-2 · Cited by 229
Viral Oncology: Molecular Biology and Pathogenesis
Mui, U. N., Haley, C. T., & Tyring, S. K. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6120111 · Cited by 238
Immune mechanisms in acetaminophen-induced acute liver failure.
Krenkel, O., Mossanen, J. C., & Tacke, F. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2304-3881.2014.11.01 · Cited by 221
Chen, Y., Huang, Y., Reiberger, T., Duyverman, A. M. M. J., Huang, P., Samuel, R., Hiddingh, L., Roberge, S., Koppel, C., Lauwers, G. Y., et al. (2013) · Hepatology · doi:10.1002/hep.26790 · Cited by 212
The gut microbiota metabolite indole alleviates liver inflammation in mice
Beaumont, M., Neyrinck, A. M., Olivares, M., Rodriguez, J., Nédélec, A., Roumain, M., Bindels, L. B., Cani, P. D., Evenepoel, P., Muccioli, G. G., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800544 · Cited by 214
Hypoxia and Inflammation in Cancer, Focus on HIF and NF-κB
D’Ignazio, L., Batie, M., & Rocha, S. (2017) · Biomedicines · doi:10.3390/biomedicines5020021 · Cited by 209
Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease
de Gregorio, E., Colell, A., Morales, A., & Marı́, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113858 · Cited by 203
Yang, Y. M., & Seki, E. (2015) · Current Pathobiology Reports · doi:10.1007/s40139-015-0093-z · Cited by 203
Hepatocyte autotaxin expression promotes liver fibrosis and cancer
Kaffe, E., Katsifa, A., Xylourgidis, N., Ninou, I., Ζαννίκου, Μ., Harokopos, V., Foka, P., Dimitriadis, A., Evangelou, K., Moulas, A. N., et al. (2016) · Hepatology · doi:10.1002/hep.28973 · Cited by 197
Chronic Activation of mTOR Complex 1 Is Sufficient to Cause Hepatocellular Carcinoma in Mice
Menon, S., Yecies, J. L., Zhang, H., Howell, J. J., Nicholatos, J. W., Harputlugil, E., Bronson, R. T., Kwiatkowski, D. J., & Manning, B. D. (2012) · Science Signaling · doi:10.1126/scisignal.2002739 · Cited by 193
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer
Schneider, C., Teufel, A., Yevsa, T., Staib, F., Hohmeyer, A., Walenda, G., Zimmermann, H. W., Vucur, M., Huss, S., Gaßler, N., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301116 · Cited by 182
Self-citationDuan, M., Goswami, S., Shi, J.-Y., Wu, L., Wang, X., Ma, J., Zhang, Z., Shi, Y., Ma, L., Zhang, S., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3040 · Cited by 185
Anson, M., Crain‐Denoyelle, A., Baud, V., Chéreau, F., Gougèlet, A., Terris, B., Yamagoe, S., Colnot, S., Viguier, M., Perret, C., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci43937 · Cited by 188
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
Shlomai, A., de Jong, Y. P., & Rice, C. M. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.01.004 · Cited by 186
NKT cell subsets as key participants in liver physiology and pathology
Bandyopadhyay, K., Marrero, I., & Kumar, V. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.115 · Cited by 176
Bakiri, L., & Wagner, E. F. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.01.005 · Cited by 173
Protein neddylation and its role in health and diseases
Zhang, S., Yu, Q., Li, Z., Zhao, Y., & Sun, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01800-9 · Cited by 171
MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives
Hochreuter, M. Y., Dall, M., Treebak, J. T., & Barrès, R. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101581 · Cited by 180
Targeted therapy for hepatocellular carcinoma: novel agents on the horizon
Cervello, M., McCubrey, J. A., Cusimano, A., Lampiasi, N., Azzolina, A., & Montalto, G. (2012) · Oncotarget · doi:10.18632/oncotarget.466 · Cited by 170
Hepatocellular Carcinoma: Causes, Mechanism of Progression and Biomarkers
Singh, A. K., Kumar, R., & Pandey, A. K. (2018) · Current Chemical Genomics · doi:10.2174/2213988501812010009 · Cited by 167
Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy
Anwar, S., Shamsi, A., Mohammad, T., Islam, A., & Hassan, M. I. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188568 · Cited by 168
Philips, G., Chan, I. S., Swiderska, M., Schroder, V. T., Guy, C. D., Karaca, G., Moylan, C. A., Venkatraman, T. N., Feuerlein, S., Syn, W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023943 · Cited by 164
Sex Hormone-Dependent Physiology and Diseases of Liver
Kur, P., Kolasa, A., Misiakiewicz-Has, K., & Wiszniewska, B. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17082620 · Cited by 168
Mitochondrial Roles and Cytoprotection in Chronic Liver Injury
Esposti, D. D., Hamelin, J., Bosselut, N., Saffroy, R., Sebagh, M., Pommier, A., Martel, C., & Lemoine, A. (2012) · Biochemistry Research International · doi:10.1155/2012/387626 · Cited by 165
Uehara, T., Pogribny, I. P., & Rusyn, I. (2014) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph1430s66 · Cited by 156
RIPK1 Suppresses a TRAF2-Dependent Pathway to Liver Cancer
Schneider, A. T., Gautheron, J., Feoktistova, M., Roderburg, C., Loosen, S. H., Roy, S., Benz, F., Schemmer, P., Büchler, M. W., Nachbur, U., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2016.11.009 · Cited by 155
Self-citationJiang, H., Chen, C., & Gao, J. (2022) · Nutrients · doi:10.3390/nu15010151 · Cited by 153
Esam, F., Khalafalla, M. M., Gewaily, M. S., Abdo, S. E., Hassan, A. M., & Dawood, M. A. O. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113187 · Cited by 144
Wang, R., Zhang, H., Wang, Y., Song, F., & Yuan, Y. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.03.029 · Cited by 145
Stellate cells and the development of liver cancer: Therapeutic potential of targeting the stroma
Coulouarn, C., & Clément, B. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.02.003 · Cited by 142
Hepatoprotective effect of sitagliptin against methotrexate induced liver toxicity
Abo‐Haded, H. M., Elkablawy, M. A., Al-johani, Z., Al-ahmadi, O., & El‐Agamy, D. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174295 · Cited by 142
Regulation of wound healing and organ fibrosis by toll-like receptors
Huebener, P., & Schwabe, R. F. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.017 · Cited by 140
Self-citationMatrix Metalloproteinases (MMPs) in Liver Diseases
Naim, A., Pan, Q., & Baig, M. S. (2017) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2017.09.004 · Cited by 145
Kondylis, V., Polykratis, A., Ehlken, H., Ochoa-Callejero, L., Straub, B. K., Krishna-Subramanian, S., Van, T.-M., Curth, H.-M., Heise, N., Weih, F., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.10.001 · Cited by 131
Domitrović, R., Škoda, M., Vasiljev, V., Cvijanović, O., Pugel, E. P., & Štefan, M. B. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.10.021 · Cited by 135
Sunami, Y., Leithäuser, F., Gul, S., Fiedler, K., Güldiken, N., Espenlaub, S., Holzmann, K., Hipp, N., Sindrilaru, A., Luedde, T., et al. (2012) · Hepatology · doi:10.1002/hep.25711 · Cited by 135
Self-citationHepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis
Yu, J., Zhu, C., Wang, X., Kim, K., Bartolome, A., Dongiovanni, P., Yates, K. P., Valenti, L., Carrer, M., Sadowski, T., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe1692 · Cited by 132
Lee, Y. A., & Friedman, S. L. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.03.012 · Cited by 132
Hepatoprotective effects of rosmarinic acid: Insight into its mechanisms of action
Elufioye, T. O., & Habtemariam, S. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108600 · Cited by 134
Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?
Khanam, A., Saleeb, P. G., & Kottilil, S. (2021) · Cells · doi:10.3390/cells10051097 · Cited by 143
Roderburg, C., Luedde, M., Cardenas, D. V., Vucur, M., Mollnow, T., Zimmermann, H. W., Koch, A. H., Hellerbrand, C., Weiskirchen, R., Frey, N., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.022 · Cited by 130
Self-citationNikolaou, K., Tsagaratou, A., Eftychi, C., Kollias, G. A., Mosialos, G., & Talianidis, I. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.026 · Cited by 129
Role of chemokine systems in cancer and inflammatory diseases
Li, H., Wu, M., & Zhao, X. (2022) · MedComm · doi:10.1002/mco2.147 · Cited by 134
Hepatocytes: A key role in liver inflammation
Gong, J., Tu, W., Liu, J., & Tian, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1083780 · Cited by 152
Bai, T., Lian, L., Wu, Y., Wan, Y., & Nan, J. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2012.12.020 · Cited by 128
Vucur, M., Reisinger, F., Gautheron, J., Janssen, J., Roderburg, C., Cardenas, D. V., Kreggenwinkel, K., Koppe, C., Hammerich, L., Hakem, R., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.035 · Cited by 127
Self-citationSLC39A8 gene encoding a metal ion transporter: discovery and bench to bedside
Nebert, D. W., & Liu, Z. (2019) · Human Genomics · doi:10.1186/s40246-019-0233-3 · Cited by 124
Liu, H., Pathak, P., Boehme, S., & Chiang, J. Y. L. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m069807 · Cited by 125
Xiong, S., Wang, R., Chen, Q., Luo, J., Wang, J., Zhao, Z., Li, Y., Wang, Y., Wang, X., & Cheng, B. (2018) · PubMed Central · Cited by 122
The roles and mechanisms of hypoxia in liver fibrosis
Cai, J., Hu, M., Chen, Z., & Ling, Z. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02854-x · Cited by 136
Molecular Pathogenesis of Hepatocellular Carcinoma
Ho, D. W., Lo, R. C., Chan, L., & Ng, I. O. (2016) · Liver Cancer · doi:10.1159/000449340 · Cited by 122
How Inflammation Impinges on NAFLD: A Role for Kupffer Cells
Duarte, N., Coelho, I. C., Patarrão, R. S., Almeida, J. I., Penha-Gonçalves, C., & Macedo, M. P. (2015) · BioMed Research International · doi:10.1155/2015/984578 · Cited by 120
Is Hepatitis C Virus Carcinogenic?
Lemon, S. M., & McGivern, D. R. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.01.045 · Cited by 129
Cano, R., Pérez, J., Dávila, L., Ortega, Á., Gómez, Y., Valero-Cedeño, N., Parra, H., Manzano, A., Véliz-Castro, T. I., Albornoz, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094807 · Cited by 121
Shen, Y., Cheng, L., Xu, M., Wang, W., Wan, Z., Xiong, H., Guo, W., Cai, M., & Xu, F. L. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155657 · Cited by 118
Zeligs, K., Neuman, M. K., & Annunziata, C. M. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1374 · Cited by 117
Jung, I., Kim, H., Moon, S., Lee, H., & Kim, B. (2020) · Antioxidants · doi:10.3390/antiox9090857 · Cited by 121
Torre, S. D. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.572490 · Cited by 125
Dash, S., Aydın, Y., Widmer, K., & Nayak, L. (2020) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s221187 · Cited by 131
Lee, I.-C., Kim, S., Baek, H., Moon, C., Kang, S. S., Kim, S., Kim, Y.-B., Shin, I., & Kim, J.-C. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.11.006 · Cited by 114
Metadata
- Authors
- Luedde, T., & Schwabe, R. F.
- Affiliations
- Universitätsklinikum Aachen (DE)
- Columbia University Irving Medical Center (US)
- Corresponding author
- Luedde, Tom
- Schwabe, Robert F.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2011-02
- Volume
- 8
- Issue
- 2
- Pages
- 108-118
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- PMC
- PMC3295539
- OpenAlex
- W1976777085
- Cited by
- 1,345
- References
- 137
- Citations by year
- 2026: 97 · 2025: 99 · 2024: 119 · 2023: 109 · 2022: 122 · 2021: 156 · 2020: 120 · 2019: 95 · 2018: 79 · 2017: 76 · 2016: 66 · 2015: 68 · 2014: 51 · 2013: 38 · 2012: 42
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5u54ca126513-03)
- National Institute on Alcohol Abuse and Alcoholism (R01AA020211)
- National Cancer Institute (U54 CA126513.)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK076920)
- National Center for Complementary and Integrative Health (R21AT003878)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Keywords
- NF-κB, liver fibrosis, hepatocellular carcinoma, chronic liver disease, liver cirrhosis, chronic liver injury, liver inflammation, hepatocytes, non-parenchymal liver cells, NF-κB inhibition, hepatocyte viability
- MeSH terms
- Cell Survival, Fibrosis, Carcinoma, Hepatocellular, Homeostasis, Humans, Liver, Liver Neoplasms, NF-kappa B, Hepatocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
